54-year-old patient is diagnosed with a deep vein thrombosis, which puts him at an increased risk for developing pulmonary embol
ism. A decision is made to initiate treatment with an anticoagulant that has an immediate onset of effect and is not dependent on the depletion of vitamin K-dependent coagulation factors. The best choice for achieving this treatment goal is:
Enoxaparin is used to treat or prevent a type of blood clot sometimes called deep vein thrombosis (DVT), which can cause blood clots in the lungs (pulmonary embolism).
